Concepedia

Rudolf Schindler

RS

Statistics

Publications

5

Citations

208

H-Index

5

Active since

2001

Affiliations

Pfizer (United States)(Current)

Charité - Universitätsmedizin Berlin

BioCrea (Germany)

Rudolf Schindler is an author at Pfizer (United States) specializing in drug discovery, drug design, and pharmacy.

Publications per year

2001–2012

5

Publications

5

Highly Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitors

Michael S. Malamas, Yike Ni, James Erdei et al. · Journal of Medicinal Chemistry · 2011 · 72 citations · Full text

, , +14

Discovery of Imidazo[1,5-<i>a</i>]pyrido[3,2-<i>e</i>]pyrazines as a New Class of Phosphodiesterase 10A Inhibitiors

Norbert Höfgen, Hans Stange, Rudolf Schindler et al. · Journal of Medicinal Chemistry · 2010 · 63 citations · Full text

, , +14

Large-Scale Isolation of Sinusoidal Endothelial Cells from Pig and Human Liver

Jörg C. Gerlach, Katrin Zeilinger, Gabriele Spatkowski et al. · Journal of Surgical Research · 2001 · 27 citations

, , +13

Novel triazines as potent and selective phosphodiesterase 10A inhibitors

Michael S. Malamas, Hans Stange, Rudolf Schindler et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 26 citations · Full text

, , +9

Optimization of a serum-free culture medium for mouse embryonic stem cells using design of experiments (DoE) methodology

Fanny Knöspel, Rudolf Schindler, Marc Lübberstedt et al. · Cytotechnology · 2010 · 20 citations · Full text

, , +14

1–5 of 5